Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial

D. Lorusso, G. Ferrandina, N. Colombo, S. Pignata, A. Pietragalla, C. Sonetto, C. Pisano, M. T. Lapresa, A. Savarese, P. Tagliaferri, D. Lombardi, S. Cinieri, E. Breda, I. Sabatucci, R. Sabbatini, C. Conte, S. C. Cecere, G. Maltese, G. Scambia

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Carboplatin-paclitaxel compared to Carboplatin-Paclitaxel-Bevacizumab in advanced or recurrent endometrial cancer: MITO END-2 - A randomized phase II trial'. Together they form a unique fingerprint.

Medicine & Life Sciences